<div id="readability-page-1"><div> <div> A roundup of the most newsworthy healthcare press releases from PR Newswire this week, including the year's best hospitals, a new initiative to expand the marrow donor registry and new AI tools from Aetna., /PRNewswire/ -- With thousands of press releases published each week, it can be difficult to keep up with everything on PR Newswire. To help healthcare journalists and consumers stay on top of the week's most newsworthy and popular releases, here's a recap of some major stories from the week that shouldn't be missed.The list below includes the headline (with a link to the full text) and an excerpt from each story. Click on the press release headlines to access accompanying multimedia assets that are available for download. Continue Reading <div> <div> <div> <div> <figure> <img id="imageid_2" src="https://imageproxy.pbkrs.com/https://www.prnewswire.com/news-releases/null?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" original-src="https://imageproxy.pbkrs.com/https://www.prnewswire.com/news-releases/null"/> <figcaption> PR Newswire Weekly Health Press Release Roundup, July 28-Aug. 1, 2025. </figcaption> </figure> </div> </div> </div> </div> <ol type="1"> <li>Gift of Life in Collaboration with Labcorp and DOUBLEMINT®, Launch Hero Gum to Expand Marrow Donor Registry By chewing a piece of gum for just five minutes, individuals can provide a viable sample for Human Leukocyte Antigen (HLA) typing and join the marrow registry — the first step toward potentially saving a life. The initiative will debut at Citi Field on August 1 during the New York Mets vs. San Francisco Giants game, where the Gift of Life team will distribute hundreds of kits to fans.</li> <li>Illumina enhances flagship assay to accelerate access to comprehensive tumor profiling From a small tissue sample, TSO 500 v2 assesses hundreds of genes across all variant classes and immuno-oncology biomarkers to facilitate therapy selection research. Research shows that when CGP is performed early in a cancer patient's diagnosis, it leads to better personalized treatment and outcomes.</li> <li>Bausch Health to Acquire DURECT Corporation, Strengthening Commitment to Developing Innovative Solutions for Patients with Liver Disease &#34;There is a significant unmet need in the treatment of patients with [alcoholic hepatitis] AH given the high mortality rate and that there are no currently approved treatments. We are very excited to add larsucosterol, an asset which has FDA Breakthrough Therapy Designation, to our pipeline,&#34; said Jonathan Sadeh M.D., M.Sc. as Executive Vice President, Chief Medical Officer and Head of R&amp;D at Bausch Health.</li> <li>Children's Hospital Colorado Partners with Denver Broncos Foundation to Study Physical, Mental Health of Female Athletes Playing Flag Football The research team found that flag football athletes had higher self-reported energy levels during the week than non-athletes, even when accounting for differences in physical activity. This led them to propose that flag football provided benefits to mental health, in addition to the physical and mental health benefits of athletic activity alone.</li> <li>MapLight Therapeutics Announces $372.5 Million Series D Financing With this financing, MapLight will advance its lead program, ML-007C-MA, through ongoing Phase 2 trials for schizophrenia and Alzheimer's disease psychosis. The financing will also fund the exploration of other potential indications for ML-007C-MA, as well as the continued advancement of other clinical and preclinical pipeline programs.</li> <li>Aetna Launches New AI and Digital Tools to Improve Access and Care This technology simplifies the member experience by giving clarity about procedures and benefits that may be encountered and personalized care recommendations, all in one convenient location. At the core of Aetna Care Paths is a US patent-pending technology that delivers personalized recommendations for programs that will support members on their healthcare journey.</li> <li>Hengrui Pharma and GSK enter agreements to develop up to 12 innovative medicines across Respiratory, Immunology &amp; Inflammation and Oncology The programs were selected to complement GSK's extensive Respiratory, Immunology &amp; Inflammation (RI&amp;I) and Oncology pipeline, and assessed for their potential best- or first-in-class profiles. GSK will pay $500 million in upfront fees across the agreements.</li> <li>After $300K Kickstarter Success, Omni Health Ring Launches 'EnerQi™': The Next-Gen Readiness Score This comprehensive, industry-first dynamic health index includes sleep, exercise, stress, nutrition, and real-time updates based on the wearer's behavior. EnerQi shifts the conversation from &#34;How did you sleep last night?&#34; to &#34;How energized are you right now, and what should you do next?&#34;</li> <li>U.S. News Announces 2025-2026 Best Hospitals The 2025-2026 edition of Best Hospitals includes the regional evaluation of hospitals at both a state and metro level. This year, U.S. News recognizes 504 Best Regional Hospitals across 49 states and 95 metro areas that have demonstrated superior outcomes.</li> <li>ARTBIO Announces $132 Million Series B Financing to Advance Pipeline of Alpha Radioligand Therapies and Expand Manufacturing and Supply Chain Infrastructure This latest round of funding will support the advancement of ARTBIO's pipeline, including its lead program, AB001, for metastatic castration-resistant prostate cancer, through Phase II clinical trials, and enable continued expansion of the company's supply chain.</li> <li>Simtra BioPharma Solutions Announces Strategic Purchase to Expand U.S. Manufacturing Capacity for Injectable Medicines Simtra announced the purchase from Cook Group of a 65-acre property with more than 300,000 square feet of available space for expansion under-roof near its existing manufacturing facility in Bloomington, Indiana. Simtra is evaluating a project to design and install manufacturing lines at the site, including the company's first U.S.-based commercial-scale capacity for oncology-focused injectable drug products. </li> </ol> For more news like this, check out all of the latest health-related releases from PR Newswire.Do you have a health press release to distribute? Sign up with PR Newswire to share your story with the audiences who matter most.Can't-Miss Healthcare EarningsIn addition to these popular releases, earnings season continued this week and several must-read health industry earnings reports crossed the wire, including the quarterly results for AbbVie, Centene Corporation and InMode.Catch up on all the latest earnings reports here.Helping Journalists Stay Up to Date on Industry NewsThese are just a few of the recent press releases that consumers and the media should know about. To be notified of releases relevant to their coverage area, journalists can set up a custom newsfeed with PR Newswire for Journalists.Once they're signed up, reporters, bloggers, and freelancers have access to the following free features:<ul type="disc"> <li>Customization: Users can create customized newsfeeds that will deliver relevant news right to their inbox. Newsfeed results can be targeted by keywords, industry, subject, geography, and more.</li> <li>Photos and Videos: Thousands of multimedia assets are available to download and include in a journalist or blogger's next story.</li> <li>Subject Matter Experts: Journalists will have access to ProfNet, a database of industry experts to connect with as sources or for quotes in their articles.</li> <li>Related Resources: Our journalist- and blogger-focused blog, Beyond Bylines, features regular media news roundups, writing tips, upcoming events, and more.</li> </ul>About PR NewswirePR Newswire is the industry's leading press release distribution partner with an unparalleled global reach of more than 440,000 newsrooms, websites, direct feeds, journalists and influencers and is available in more than 170 countries and 40 languages. From our award-winning Content Services offerings, integrated media newsroom and microsite products, Investor Relations suite of services, paid placement and social sharing tools, PR Newswire has a comprehensive catalog of solutions to solve the modern-day challenges PR and communications teams face. For 70 years, PR Newswire has been the preferred destination for brands to share their most important news stories across the world.For questions, contact the team at [email protected].SOURCE PR Newswire<img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjUwODAxJk5ld3NJdGVtSWQ9Tlk0MjI3NyZUcmFuc21pc3Npb25fSWQ9MjAyNTA4MDEwNjIyUFJfTkVXU19VU1BSX19fX19OWTQyMjc3?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" original-src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjUwODAxJk5ld3NJdGVtSWQ9Tlk0MjI3NyZUcmFuc21pc3Npb25fSWQ9MjAyNTA4MDEwNjIyUFJfTkVXU19VU1BSX19fX19OWTQyMjc3"/></div> </div></div>

DRRX

This week's recap highlights significant healthcare press releases, including a new initiative by Gift of Life to expand the marrow donor registry, Bausch Health's acquisition of DURECT Corporation, and Aetna's launch of AI tools to enhance member care. Other notable stories include Children's Hospital Colorado's research on female flag football athletes, MapLight Therapeutics' $372.5 million financing, and U.S. News' recognition of the 2025-2026 Best Hospitals. The roundup emphasizes advancements in healthcare and innovative solutions for patient care.

06:22 ET Weekly Recap: 11 Health Press Releases You Need to See